Skip to main content
. Author manuscript; available in PMC: 2018 Jun 1.
Published in final edited form as: Clin Cancer Res. 2017 Sep 12;23(23):7324–7332. doi: 10.1158/1078-0432.CCR-17-1561

Figure 6. Recurrence of laryngeal cancer is associated with greater rates of TMEM16A overexpression.

Figure 6

A: Clinical and demographic data of n = 41 cases of laryngeal cancer; cases were separated by the absence (n = 27) or presence (n = 14) of disease recurrence. P-values calculated by two-sided Fisher’s Exact Test. B: Primary tumors that did not recur (PrimaryNR) had a significantly smaller proportion of tumors overexpressing TMEM16A than primary tumors that did recur (PrimaryR). Threshold of overexpression (red dotted line) was defined as the mean H-Score of PrimaryNR. Lines represent mean −/+ 95% CI. *p < .05 calculated by Fisher’s Exact Test.